Unraveling interindividual variation of trimethylamine N‐oxide and its precursors at the population level

• Published in: iMeta 2024-06, Vol.3 (3), p.e183-n/a
• Main Authors: Andreu‐Sánchez, Sergio, Ahmad, Shahzad, Kurilshikov, Alexander, Beekman, Marian, Ghanbari, Mohsen, Faassen, Martijn, Munckhof, Inge C. L., Steur, Marinka, Harms, Amy, Hankemeier, Thomas, Ikram, M. Arfan, Kavousi, Maryam, Voortman, Trudy, Kraaij, Robert, Netea, Mihai G., Rutten, Joost H. W., Riksen, Niels P., Zhernakova, Alexandra, Kuipers, Folkert, Slagboom, P. Eline, Duijn, Cornelia M., Fu, Jingyuan, Vojinovic, Dina
• Format: Article
• Language: English
• Subjects: diet; genetics; gut microbiome; meta‐analysis; population cohort; TMAO
• ISSN: 2770-596X; 2770-5986; 2770-596X
• DOI: 10.1002/imt2.183

Trimethylamine N‐oxide (TMAO) is a circulating microbiome‐derived metabolite implicated in the development of atherosclerosis and cardiovascular disease (CVD). We investigated whether plasma levels of TMAO, its precursors (betaine, carnitine, deoxycarnitine, choline), and TMAO‐to‐precursor ratios are associated with clinical outcomes, including CVD and mortality. This was followed by an in‐depth analysis of their genetic, gut microbial, and dietary determinants. The analyses were conducted in five Dutch prospective cohort studies including 7834 individuals. To further investigate association results, Mendelian Randomization (MR) was also explored. We found only plasma choline levels (hazard ratio [HR] 1.17, [95% CI 1.07; 1.28]) and not TMAO to be associated with CVD risk. Our association analyses uncovered 10 genome‐wide significant loci, including novel genomic regions for betaine (6p21.1, 6q25.3), choline (2q34, 5q31.1), and deoxycarnitine (10q21.2, 11p14.2) comprising several metabolic gene associations, for example, CPS1 or PEMT. Furthermore, our analyses uncovered 68 gut microbiota associations, mainly related to TMAO‐to‐precursors ratios and the Ruminococcaceae family, and 16 associations of food groups and metabolites including fish‐TMAO, meat‐carnitine, and plant‐based food‐betaine associations. No significant association was identified by the MR approach. Our analyses provide novel insights into the TMAO pathway, its determinants, and pathophysiological impact on the general population. Measurements of trimethylamine N‐oxide and its precursors in plasma samples from five population cohorts identified an association between choline concentrations and cardiovascular disease. The interindividual variability of metabolite concentrations was determined by common genetic variation, dietary patterns, and the gut microbial composition of the population. Highlights Exploration of microbiome‐related metabolites (trimethylamine N‐oxide [TMAO], choline, betaine, l‐carnitine, and deoxycarnitine) in 7834 participants from five population cohorts. Cardiovascular risk was associated with elevated choline concentrations, but not with TMAO concentrations. Characterization of the genetic architecture behind metabolite concentration variability. Identification of gut microbial taxonomic abundance associated with metabolite's plasma concentration levels. Fish intake is the major dietary driver of TMAO concentrations, and betaine is related to grains and vegetable inta